Company Filing History:
2 out of 15,528 
2 out of 917 
3 out of 832,912 Years Active: 1992-1998
Title: The Innovations of Tadatsugu Taniguchi
Introduction
Tadatsugu Taniguchi is a notable inventor based in Ibaraki-shi, Osaka, Japan. He has made significant contributions to the field of biotechnology, particularly in the diagnosis and treatment of tumorigenic cells. With a total of 3 patents to his name, his work has the potential to impact cancer research and treatment.
Latest Patents
One of his latest patents focuses on "Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity." This invention relates to a method for diagnosing tumorigenic mammalian cells and assessing the propensity of these cells to become tumorigenic. The patent also includes a cloned cDNA or genomic DNA aimed at reducing the likelihood of a cell becoming tumorigenic. Furthermore, it outlines methods for treating patients who are suffering from or predisposed to cancer development, as well as diagnosing tumorigenic tissue in humans.
Career Highlights
Throughout his career, Taniguchi has worked with various institutions, including the University of California. His research has contributed to advancements in understanding tumorigenicity and developing diagnostic methods that could lead to better patient outcomes.
Collaborations
Taniguchi has collaborated with esteemed colleagues such as Cheryl L. Willman and Maria G. Pallavicini. These partnerships have likely enriched his research and expanded the impact of his inventions.
Conclusion
Tadatsugu Taniguchi's work in the field of biotechnology, particularly regarding tumorigenicity, showcases his innovative spirit and dedication to improving cancer diagnosis and treatment. His contributions are invaluable to the ongoing fight against cancer.